Table 2.
FABP dysregulation in cancer
| Cancer type | FABP(s) | Association | Reference |
|---|---|---|---|
| Intestine | FABP1 | FABP1 deletion protects against tumorigenesis in a small intestinal adenoma mouse model | 32 |
| Enhanced FABP1 expression in small intestine epithelial cells promotes tumorigenesis | 1 | ||
| FABP4 | High expression has been shown in colon cancer tissue | 173 | |
| FABP5 | FABP5 upregulation promotes proliferation in colon cancer cells | 153 | |
| FABP7 | High expression correlates with cell proliferation in colon cancer tissues | 117 | |
| Gastrointestinal stromal cancer | FABP3 | High FABP3 protein expression | 22 |
| Gastric | FABP5 | FABP5 knockdown decreases proliferation | 201 |
| Esophageal | FABP3 | High FABP3 protein expression | 29 |
| Liver | FABP1 | High FABP1 protein expression in hepatocellular carcinoma tissues | 93 |
| FABP4 | High expression in liver cancer stem cells | 193 | |
| High expression in hepatic stellate cells in hepatocellular carcinoma | 26 | ||
| Non-small cell lung cancer | FABP3 | High FABP3 mRNA and protein expression in NSCLC tumor tissues | 171 |
| FABP5 | Knockdown decreases proliferation of lung adenocarcinoma cells | 52 | |
| FABP7 | FABP7 is prometastatic in NSCLC cell lines | 9 | |
| Breast | FABP2 | Transcriptional modulation by hormones and microenvironment in culture cells | 113 |
| FABP3 | Transcriptional modulation by hormones and microenvironment in culture cells | 113 | |
| High protein expression in tumor tissues and adipose microenvironment | 110 | ||
| FABP4 | High protein expression in tumor tissues and adipose microenvironment | 110 | |
| FABP5 | High protein expression in tumor tissues and adipose microenvironment | 110 | |
| FABP7 | High expression of FABP7 in human triple-negative breast cancer tissue | 108 | |
| Uterine sarcoma | FABP3 | High FABP3 expression in tumor tissues | 30 |
| Ovary | FABP4 | High expression in ovarian cancer tissues | 56 |
| Melanoma | FABP8 | High FABP8 protein expression | 59 |
| FABP7 | FABP7 knockdown decreased proliferation in melanoma cell lines | 176 | |
| Squamous cell carcinoma | FABP7 | FABP7 levels reduced in patient samples | 168 |
| Renal | FABP5 | FABP5 silencing inhibited proliferation of renal clear cell carcinoma cells | 114 |
| Prostate cancer | FABP5 | Knockdown of FABP5 decreases proliferation in vitro | 132 |
| FABP9 | High FABP9 protein expression in cultured cells | 3 | |
| FABP12 | FABP12 in metastatic prostate cancer | 106 | |
| Bladder | FABP6 | FABP6 knockdown decreases cell cycle progression and migration in vitro | 105 |
| Glioma | FABP4 | High expression in glioblastoma tissue and cell lines | 111 |
| FABP5 | Suppression of FABP5 decreases proliferation in vitro | 180 | |
| FABP6 | Knockdown of FABP6 in glioblastoma cells reduced tumor cell invasion | 137 | |
| FABP7 | Overexpression of FABP7 increases proliferation of glioblastoma cells | 81 | |
| Overexpression of FABP7 protective in glioma cell line | 74 | ||
| Neuroblastoma | FABP4 | High expression in tumor-associated macrophages in neuroblastoma | 123 |
| Leukemia | FABP4 | High expression in acute myeloid leukemia cells | 195 |
| Lymphoma | FABP7 | Ectopic expression in patients with large B cell lymphoma | 112 |
Abbreviations: FABP, fatty acid–binding protein; NSCLC, non-small cell lung cancer.